ProCE Banner Activity

Moderate to Severe Atopic Dermatitis: Targeted Pathways and Strategies to Personalize Patient Care

Slideset Download
Gain expert insights on personalizing care for patients with moderate to severe AD, including choosing among current treatment options, understanding emerging therapies, and recommending vaccinations for patients receiving immunosuppressants and immunomodulatory therapies for AD.

Released: May 18, 2022

Expiration: May 17, 2023

No longer available for credit.

Share

Faculty

Sarah Lant

Sarah Lant, PharmD

Clinical Pharmacist Specialist
UChicago Medicine
Chicago, Illinois

Jamie L. McConaha

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES

Associate Professor of Pharmacy Practice
Duquesne University Mylan School of Pharmacy
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Incyte Corporation